LabCompass

Naoki Furuya

Medicine · The Ohio State University

Established · publishing since 1970Rising activity

Publications

291

Citations

2,743

Est. group size

~2

Recurring co-author estimate

Active years

57

Publishing since 1970

Research summary
AI-generated

Naoki Furuya's research focuses on non-small cell lung cancer (NSCLC), particularly how genetic mutations such as EGFR, ALK, and RET affect treatment response and drug resistance. The work spans clinical trials comparing chemotherapy, immunotherapy, and targeted drugs, as well as laboratory studies of molecular signaling pathways that allow cancer cells to become resistant to targeted therapies. This research aims to help clinicians choose the most effective treatment strategies for different subtypes of lung cancer.

Lung cancer treatment and drug resistanceEGFR and other oncogenic mutations in NSCLCImmunotherapy and PD-L1 biomarkersClinical trials for targeted and combination therapiesPrognostic and predictive biomarkers

Publication output has grown substantially over the past decade, rising from single digits in 2017 to over 60 publications per year by 2023 and 2025, indicating a strong and increasing rate of research activity.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 37.4/year recently
2017: 8 publications172018: 10 publications182019: 14 publications192020: 19 publications202021: 26 publications212022: 16 publications222023: 64 publications64232024: 41 publications242025: 64 publications64252026: 2 publications26
Recent publications
Publishes in
  • Journal of Clinical Oncology×33
  • Annals of Oncology×21
  • Journal of Thoracic Oncology×18
  • Lung Cancer×12
  • Thoracic Cancer×7
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile